Resident macrophages activated by lipopolysaccharide suppress muscle tension and initiate inflammatory response in the gastrointestinal muscle layer.
A great number of macrophages is found to be evenly distributed in the muscle layer of the gastrointestinal tract. We investigated their effects on smooth muscle contraction and the initiation of immune reactions such as inflammatory responses. Macrophages were demonstrated by the uptake of FITC-dextran and their ultrastructural features were elucidated by electron microscopy. Muscle layers of rats' ilea were incubated with lipopolysaccharide (LPS) for 4-8 h and the force of smooth muscle contraction was measured. The induction effect of inducible nitric oxide synthase (iNOS) on macrophages was then checked by immunohistochemistry. The expression of major histocompatibility complex (MHC) class II was also examined. Macrophages in the muscle layer were confirmed as resident macrophages and were different from a population of dendritic cells. After incubation with LPS, macrophages began to express iNOS and produced NO, and it reduced smooth muscle contraction. iNOS-immunopositive cells increased in a time-dependent manner. Macrophages also began to express MHC class II. The total number of macrophages did not alter after incubation. Results indicate that resident macrophages in the muscle layer induced iNOS as an inflammatory reaction, affected smooth muscle contraction, and initiated immune response in the smooth muscle layer of the gastrointestinal tract, when activated by LPS.
Torihashi
S
S
Department of Anatomy, Nagoya University School of Medicine, Tsurumai, Japan. storiha@tsuru.med.nagoya-u.ac.jp
Ozaki
H
H
Hori
M
M
Kita
M
M
Ohota
S
S
Karaki
H
H
D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D002465:Cell Movement; D003911:Dextrans; D004064:Digestive System / Q000166:cytology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D016650:Fluorescein-5-isothiocyanate / Q000031:analogs & derivatives; D006146:Guanidines / Q000494:pharmacology; D000949:Histocompatibility Antigens Class II / Q000096:biosynthesis / Q000276:immunology; D007150:Immunohistochemistry; D007413:Intestinal Mucosa / Q000166:cytology; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008262:Macrophage Activation / Q000187:drug effects*; D008264:Macrophages / Q000276:immunology / Q000502:physiology* / Q000648:ultrastructure; D008297:Male; D018613:Microscopy, Confocal; D009119:Muscle Contraction / Q000187:drug effects* / Q000502:physiology; D009130:Muscle, Smooth / Q000166:cytology* / Q000187:drug effects; D009220:Myositis / Q000209:etiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000276:immunology; D052247:Nitric Oxide Synthase Type II; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors; D019323:omega-N-Methylarginine / Q000494:pharmacology
D003911:Dextrans; D004791:Enzyme Inhibitors; D006146:Guanidines; D000949:Histocompatibility Antigens Class II; D008070:Lipopolysaccharides; C015219:fluorescein isothiocyanate dextran; D019323:omega-N-Methylarginine; D002217:Carbachol; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496318:Nos2 protein, rat; D016650:Fluorescein-5-isothiocyanate; C004479:pimagedine